INTERPACE BIOSCIENCES, INC. (IDXG) Net margin 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) net profit margin by fiscal year — reported net income divided by reported revenue.
63.5%FY2025 · since FY2016: -168.2% → 63.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 63.5% | +49.2 pp |
| FY2024 | 14.3% | +9.3 pp |
| FY2023 | 5.0% | +74.0 pp |
| FY2022 | -69.0% | -23.8 pp |
| FY2021 | -45.1% | +36.5 pp |
| FY2020 | -81.6% | +28.8 pp |
| FY2019 | -110.4% | -52.4 pp |
| FY2018 | -58.0% | -137.0 pp |
| FY2017 | 79.0% | +247.1 pp |
| FY2016 | -168.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice